Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

Trial Profile

Comparison of Single Versus Repeat Doses of AM-101 in the Treatment of Acute Inner Ear Tinnitus

Completed
Phase of Trial: Phase II

Latest Information Update: 20 Apr 2015

At a glance

  • Drugs Esketamine (Primary)
  • Indications Tinnitus
  • Focus Therapeutic Use
  • Acronyms TACTT1
  • Sponsors Auris Medical
  • Most Recent Events

    • 20 Apr 2015 According to an Auris Medical media release, results from this trial were published in Audiology and Neurotology journal.
    • 20 Apr 2015 Primary endpoint 'The change in tinnitus loudness by magnitude estimation from Baseline to 90 days following the last injection' has not been met, according to an Auris Medical media release.
    • 18 Sep 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top